ADAPT-Treated porcine valve tissue (cusp and wall) versus medtronic freestyle and prima plus: Crosslink stability and calcification behavior in the subcutaneous rat model

Journal of Heart Valve Disease

Volumn 13, Issue 4, 2004, Pages 689-696

  Neethling, William M L ^a   Glancy, Ross ^b   Hodge, Andrew J ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CELLULOSE; CROSS LINKING REAGENT; DRUG DERIVATIVE; EDETIC ACID; FIXATIVE; GLUTARALDEHYDE; THIOMERSAL;

ANIMAL; AORTA VALVE; ARTICLE; BIOLOGICAL MODEL; BIOPROSTHESIS; CALCINOSIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG COMBINATION; HEART VALVE PROSTHESIS; HOSPITALIZATION; MALE; MEDICAL INSTRUMENTATION; METABOLISM; PATHOLOGY; PROSTHESIS; RAT; SWINE; WISTAR RAT;

ANIMALS; AORTIC VALVE; BIOPROSTHESIS; CALCINOSIS; CALCIUM; CELLULOSE; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DURABLE MEDICAL EQUIPMENT; EDETIC ACID; FIXATIVES; GLUTARAL; HEART VALVE PROSTHESIS; MALE; MODELS, CARDIOVASCULAR; PROSTHESIS DESIGN; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SWINE; THIMEROSAL;

EID: 7044231251     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Milano A, Bortolotti U, Talenti E, et al. Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol 1984;53:1066-1070 (Pubitemid 14174253)
2. Valente M, lus P, Bortolotti U, Talenti E, Bottio T, Thiene G. Pathology of the Pericarbon bovine pericardial xenograft implanted in humans. J Heart Valve Dis 1998;7:180-189 (Pubitemid 28168496)
3. Neethling WML, Van den Heever JJ, Meyer JM, Barnard HC. Processing factors as determinants of tissue valve calcification. J Cardiovasc Surg 1992;3:285-291
4. Miller DC, Stinson EB, Oyer PE, et al. The durability of porcine xenograft valves and conduits in children. Circulation 1982;66(Suppl.I):172-185
5. Liao K, Seifter E, Hoffman D, Yellin EL, Frater RW. Bovine pericardium versus porcine aortic valve: Comparison of tissue biological properties as prosthetic valves. Artif Organs 1992;16:361-365
6. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983;86:115125
7. Deiwick M, Glasmacher B, Baba HA, et al. In vitro testing of bioprostheses: Influence of mechanical stresses and lipids on calcification. Ann Thorac Surg 1998;66(6 Suppl.):S206-211 (Pubitemid 29087162)
8. Woodroof EA. Use of glutaraldehyde and formaldehyde to process tissue heart valves. J Bioeng 1978;2:1-9 (Pubitemid 8346265)
9. Huang-Lee LLH, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with degradation of polymeric glutaraldehyde derived cross-links. J Biomed Mater Res 1990;24:1185-1201 (Pubitemid 20269711)
10. Hughes H, Tipton LS, Feuchuk D, Prabhakar G, Aboul-Enein HY, Duran CM. Glutaraldehyde, gamma-carboxyglutamic acid and calcium in explanted bioprosthetic heart valves. J Heart Valve Dis 1994;3:111-116 (Pubitemid 24049965)
11. Golomb G, Schoen FJ, Smith MS, Lindin J, Dixon M, Levy RJ. The role of glutaraldehyde-induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130 (Pubitemid 17062594)
12. .Thoma RJ, Phillips RE. The role of material surface chemistry in implant device calcification: A hypothesis. J Heart Valve Dis 1995;4:214-221
13. Levy RJ, Schoen FJ, Lund SA, Smith MS. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. J Thorac Cardiovasc Surg 1987;94:551-557
14. Levy RJ, Schoen FJ, Flowers WB, Staelin ST. Initiation of mineralization in bioprosthetic heart valves: Studies of alkaline phosphatase activity and its inhibition by AlCb or FeCb preincubations. J Biomed Mater Res 1991;25:905-935
15. Gott JP, Chih P, Dorsey LM, et al. Calcification of porcine valves: A successful new method of antimineralization. Ann Thorac Surg 1992;53:207-216
16. Vyavahare N, Hirsch D, Lerner E, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Circulation 1997;95:479-488 (Pubitemid 27056217)
17. Williams MA. The INTACT bioprosthesis-early results. J Card Surg 1988; 3(3 Suppl.):347-351
18. .Oury JH, Angelí WW, Koziol JA. Comparison of Hancock I and Hancock II bioprostheses. J Card Surg 1988;3(3 Suppl.):375-381
19. David TE, Feindel CM, Scully HE, Bos J, Rakowski H. Aortic valve replacement with stentless porcine aortic valves: A ten-year experience. J Heart Valve Dis 1998;7:250-254 (Pubitemid 28266843)
20. .Melina G, Rubens MB, Birks EJ, Bizzarri F, Khaghani A, Yacoub MH. A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized trial. J Heart Valve Dis 2000;9:97-103
21. .Herijgers P, Ozaki S, Verbeken E, et al. The NoReact anticalcification treatment: A comparison of Biocor No-React II and Toronto SPV stentless bioprostheses implanted in sheep. Semin Thorac Cardiovasc Surg 1999;11(4 Suppl.l):171-175
22. .Flameng W, Ozaki S, Meuris B, et al. Antirrtineralization treatments in stentless porcine bioprostheses: An experimental study. J Heart Valve Dis 2001;10:489-494 (Pubitemid 32685068)
23. Westaby S, Bianco RW, Katsumata T, Termin P. The CarboMedics 'Oxford' Photofix stentless valve (PSV). Semin Thorac Cardiovasc Surg 1999;11(4 Suppl.l):206-209
24. Zilla P, Weissenstein C, Bracher M, et al. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue. J Heart Valve Dis 1997;6:502-509 (Pubitemid 27405125)
25. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis 2000;9:230-240 (Pubitemid 30187005)
26. Trantina-Yates AE, Human P, Zilla P. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model. J Heart Valve Dis 2003;12:93-100
27. Richards FM, Knowles JR. Glutaraldehyde as a protein cross-linking reagent. J MoI Biol 1968;37:231233
28. .Girardot JM, Girardot MN. Amide cross-linking: An alternative to glutaraldehyde fixation. J Heart Valve Dis 1996;5:518-525
29. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-532 (Pubitemid 15065726)
30. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, Lund SA. Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol 1986;122:71-82 (Pubitemid 16108548)
31. Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol 1999;154:843-852 (Pubitemid 29122603)
32. .Zeeman R, Dijkstra PJ, van Wachem PB, et al. Successive epoxy and carbodiimide cross-linking of dermal sheep collagen. Biomaterials 1999;20:921931
33. Petite H, Rault I, Hue A, et al. Use of the acyl azide method for cross-linking collagen-rich tissues such as pericardium. J Biomed Mater Res 1990;24:179-187
34. Girardot MN, Torrianni M, Dillehay D, et al. Role of glutaraldehyde in calcification of porcine heart valves: Comparing cusp and wall. J Biomed Mater Res 1995;12:793-801
35. Biedrzycki LM, Lerner E, Levy RJ, et al. Differential calcification of cusps and aortic wall of failed stented porcine bioprosthetic valves. J Biomed Mater Res 1997;34:411-415 (Pubitemid 27104923)
36. Singla A, Lee CH. Effect of elastin on the calcification rate of collagen-elastin matrix systems. J Biomed Mater Res 2002;60:368-374
37. Mako WJ, Shah A, Vesely I. Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: Analysis of variations in implant site and cuspal quadrants. J Biomed Mater Res 1999;45:209-213 (Pubitemid 29165936)